ICD-10 Diagnosis Code T80.89XA

Oth comp fol infusion, transfuse and theraputc inject, init

Diagnosis Code T80.89XA

ICD-10: T80.89XA
Short Description: Oth comp fol infusion, transfuse and theraputc inject, init
Long Description: Other complications following infusion, transfusion and therapeutic injection, initial encounter
This is the 2018 version of the ICD-10-CM diagnosis code T80.89XA

Valid for Submission
The code T80.89XA is valid for submission for HIPAA-covered transactions.

Code Classification
  • Injury, poisoning and certain other consequences of external causes (S00–T98)
    • Complications of surgical and medical care, not elsewhere classified (T80-T88)
      • Comp following infusion, transfusion and theraputc injection (T80)

Information for Medical Professionals

Convert to ICD-9 Additional informationCallout TooltipGeneral Equivalence Map
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.

Synonyms
  • Abdominal hernia as complication of peritoneal dialysis
  • Acute disorder of hemodialysis
  • Acute disorder of hemodialysis
  • Acute disorder of hemodialysis
  • Acute megaloblastic anemia
  • Acute megaloblastic anemia
  • Acute megaloblastic anemia due to dialysis
  • Acute megaloblastic anemia secondary to total parenteral nutrition
  • Adynamic bone disease
  • Allergic transfusion reaction
  • Alloimmune platelet transfusion refractoriness
  • Alloimmune thrombocytopenia
  • Anaphylactoid reaction to dialysis
  • Bloodstained peritoneal dialysis effluent
  • Complication of injection
  • Complication of introduction procedure
  • Dialysis dementia
  • Dialysis disequilibrium syndrome
  • Dialysis fluid adverse reaction
  • Dialysis membrane-induced anaphylactoid reaction
  • Dialysis-associated ascites
  • Dialysis-associated hypoxia
  • Encapsulating peritoneal sclerosis associated with peritoneal dialysis
  • Erythema at injection site
  • Erythrocytosis due to autotransfusion
  • Extravasation following blood transfusion
  • Extravasation injury
  • First use syndrome of dialysis
  • Hematoma of dialysis access site
  • Hemodialysis fluid adverse reaction
  • Hemodialysis-associated pruritus
  • Hemodialysis-associated pseudoporphyria
  • Hemofiltration solution adverse reaction
  • Hemolytic transfusion reaction
  • Hemoperitoneum as complication of peritoneal dialysis
  • Hemorrhage into peritoneal cavity
  • Hemosiderosis
  • Hydrothorax
  • Hydrothorax as complication of peritoneal dialysis
  • Hypercalcemia associated with chronic dialysis
  • Hyperchloremic acidosis associated with dialysis
  • Inadequate hemodialysis
  • Inadequate peritoneal dialysis
  • Induration at injection site
  • Injection neuropathy
  • Injection site anesthesia
  • Injection site atrophy
  • Injection site bruising
  • Injection site burning
  • Injection site cyst
  • Injection site dermatitis
  • Injection site edema
  • Injection site fibrosis
  • Injection site hemorrhage
  • Injection site hypersensitivity
  • Injection site induration
  • Injection site inflammation
  • Injection site irritation
  • Injection site malabsorption
  • Injection site mass
  • Injection site mass
  • Injection site necrosis
  • Injection site nerve damage
  • Injection site pain
  • Injection site paresthesia
  • Injection site pigmentation change
  • Injection site thrombosis
  • Injection site urticaria
  • Intravasation of drug or medicament
  • Lipoatrophy
  • Lipoatrophy caused by injected drug
  • Lipogranuloma
  • Localized adverse reaction caused by administration of drug
  • Localized lipoatrophy
  • Long-term disorder of dialysis
  • Loss of solute clearance
  • Megaloblastic anemia due to hemodialysis
  • Megaloblastic anemia due to total parenteral nutrition
  • Metabolic acidosis, normal anion gap, acidifying salts
  • Nontraumatic hemoperitoneum
  • Pain during inflow of dialysate
  • Pain during outflow of dialysate
  • Penile sclerosing lipogranuloma
  • Penile sclerosing lipogranuloma caused by injected substance
  • Peritoneal dialysis solution adverse reaction
  • Pseudoporphyria
  • Pulmonary transfusion reaction
  • Sclerosing lipogranuloma
  • Sclerosing peritonitis
  • Sclerosing peritonitis as complication of peritoneal dialysis
  • Skin lesion associated with hemodialysis
  • Skin lesion associated with hemodialysis
  • Swelling at injection site
  • Thrombocytopenia due to extracorporeal circulation of blood
  • Thromboembolism following infusion, perfusion AND/OR transfusion
  • Transfusion hemosiderosis
  • Transfusion reaction caused by toxic effect of anticoagulant
  • Transfusion reaction caused by toxic substance in blood
  • Transfusion reaction due to products of cell metabolism
  • Underdialysis
  • Urticarial transfusion reaction

Previous Code
Previous Code T80.89
Next Code
T80.89XD Next Code